The Emerging Regulation of VEGFR-2 in Triple-Negative Breast Cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Emerging Regulation of VEGFR-2 in Triple-Negative Breast Cancer
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2015-10-09
DOI
10.3389/fendo.2015.00159
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase III trial of sunitinib (SU) in combination with capecitabine (C) versus C in previously treated advanced breast cancer (ABC).
- (2017) J. Crown et al. JOURNAL OF CLINICAL ONCOLOGY
- Regulation of vascular endothelial growth factor in prostate cancer
- (2015) S. de Brot et al. ENDOCRINE-RELATED CANCER
- Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulateVEGFR2in breast cancer cells
- (2015) Neil T. Pfister et al. GENES & DEVELOPMENT
- Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial
- (2015) Sandro Pignata et al. LANCET ONCOLOGY
- A Recurrent Activating PLCG1 Mutation in Cardiac Angiosarcomas Increases Apoptosis Resistance and Invasiveness of Endothelial Cells
- (2014) K. Kunze et al. CANCER RESEARCH
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2
- (2014) D Zhao et al. ONCOGENE
- The power of VEGF (vascular endothelial growth factor) family molecules
- (2013) Jean-Leon Thomas et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Pazopanib, a new therapy for metastatic soft tissue sarcoma
- (2013) Jaap Verweij et al. EXPERT OPINION ON PHARMACOTHERAPY
- Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial
- (2013) Usha Chakravarthy et al. LANCET
- Axitinib for the Management of Metastatic Renal Cell Carcinoma
- (2013) Bernard Escudier et al. Drugs in research & development
- Estrogen and Cancer
- (2012) Jing Liang et al. Annual Review of Physiology
- A matter of life and death: self-renewal in stem cells
- (2012) Elaine Fuchs et al. EMBO REPORTS
- Safety and tolerability of pazopanib in the treatment of renal cell carcinoma
- (2012) Andrea Zivi et al. Expert Opinion On Drug Safety
- First-Line Treatment of Advanced Breast Cancer With Sunitinib in Combination With Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III Study
- (2012) Jonas Bergh et al. JOURNAL OF CLINICAL ONCOLOGY
- Autocrine VEGF–VEGFR2–Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth
- (2012) Petra Hamerlik et al. JOURNAL OF EXPERIMENTAL MEDICINE
- VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart
- (2011) Jun-Ming Tang et al. CARDIOVASCULAR RESEARCH
- Anti–Vascular Endothelial Growth Factor Therapy for Breast Cancer: Can We Pick the Winners?
- (2011) Bryan P. Schneider et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Placebo-Controlled, Double-Blind, Phase II Study of Axitinib Plus Docetaxel Versus Docetaxel Plus Placebo in Patients With Metastatic Breast Cancer
- (2011) Hope S. Rugo et al. JOURNAL OF CLINICAL ONCOLOGY
- Once on 'Fast Track,' Avastin Now Derailed
- (2011) J. Couzin-Frankel et al. SCIENCE
- Vascular endothelial growth factor receptor-2 in breast cancer
- (2010) Shanchun Guo et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Mechanisms of Stem Cell Self-Renewal
- (2009) He Shenghui et al. Annual Review of Cell and Developmental Biology
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
- (2009) John M.L. Ebos et al. CANCER CELL
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Dysfunctional Microvasculature as a Consequence of Shb Gene Inactivation Causes Impaired Tumor Growth
- (2009) N. S. Funa et al. CANCER RESEARCH
- Tumor and Host-Mediated Pathways of Resistance and Disease Progression in Response to Antiangiogenic Therapy
- (2009) J. M. L. Ebos et al. CLINICAL CANCER RESEARCH
- Effect of VEGF on the Regenerative Capacity of Muscle Stem Cells in Dystrophic Skeletal Muscle
- (2009) Bridget M Deasy et al. MOLECULAR THERAPY
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer
- (2008) Sriparna Ghosh et al. HUMAN PATHOLOGY
- Phase II Study of Sunitinib Malate, an Oral Multitargeted Tyrosine Kinase Inhibitor, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
- (2008) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
- Self-renewal and expansion of single transplanted muscle stem cells
- (2008) Alessandra Sacco et al. NATURE
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started